SUBSCRIBE
SUBSCRIBE

TMX Newsfile

IN THE PRESS
Press Releases
Yellowbird Diagnostics Announces First Patients Dosed in Phase 1 Trial of NeuCavis(TM)
April 15, 2026
 · 
2 min read
Press Releases
Cardiol Therapeutics to Highlight MAVERIC Phase III Trial and Recently Published ARCHER Results in Live Interview with Barchart
April 14, 2026
 · 
4 min read
Press Releases
BioMark Diagnostics to Present Liquid Biopsy Platform at the Canadian Thoracic Society Research Forum
April 14, 2026
 · 
4 min read
Press Releases
Kiora’s Phase 1 ABACUS Study of KIO-301 in Retinitis Pigmentosa Published in Nature Medicine; Phase 2 Trial Underway
April 14, 2026
 · 
6 min read
Press Releases
Telo Genomics Announces Study with University of Athens to Advance Next-Generation MRD Risk Stratification in Multiple Myeloma
April 14, 2026
 · 
6 min read
Press Releases
Marvel Biosciences Announces an Amendment to the Conversion Price for Marvel’s Proposed Convertible Debenture Offering
April 13, 2026
 · 
3 min read
Press Releases
OS Therapies Appoints Biotech Industry Luminary Robert “Bob” S. Langer, PhD as Strategic Advisor
April 13, 2026
 · 
8 min read
Press Releases
Phio Pharmaceuticals Announces “Nobel Prize Winning Science Takes on Skin Cancer” in a Fireside Chat with Force Family Office on Wednesday, April 15, 2026
April 13, 2026
 · 
5 min read
Press Releases
PharmaTher Announces Filing of U.S. Patent Application for its Peptide Microneedle Patch Technology
April 13, 2026
 · 
8 min read
Press Releases
Theralase(R) Reports Complete Response with X-Ray-Activated Rutherrin(R) in Muscle Invasive Bladder Cancer Preclinical Study
April 13, 2026
 · 
6 min read
Load More
15 Toronto St., Suite 601 Toronto ON M5C 2E3 US
Tel: 416-806-1750
Visit website
Email Us